↓ Skip to main content

The efficacy of N-Acetylcysteine in severe COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial

Overview of attention for article published in Trials, April 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (71st percentile)

Mentioned by

twitter
7 tweeters

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
65 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The efficacy of N-Acetylcysteine in severe COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial
Published in
Trials, April 2021
DOI 10.1186/s13063-021-05242-4
Pubmed ID
Authors

Arash Rahimi, Hamid Reza Samimagham, Mehdi Hassani Azad, Dariush Hooshyar, Mohsen Arabi, Mitra KazemiJahromi

Twitter Demographics

The data shown below were collected from the profiles of 7 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 65 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 7 11%
Researcher 6 9%
Other 4 6%
Student > Ph. D. Student 3 5%
Student > Master 3 5%
Other 12 18%
Unknown 30 46%
Readers by discipline Count As %
Medicine and Dentistry 12 18%
Pharmacology, Toxicology and Pharmaceutical Science 6 9%
Nursing and Health Professions 4 6%
Business, Management and Accounting 2 3%
Unspecified 2 3%
Other 6 9%
Unknown 33 51%

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 November 2021.
All research outputs
#5,108,901
of 21,323,497 outputs
Outputs from Trials
#1,776
of 5,444 outputs
Outputs of similar age
#99,880
of 349,618 outputs
Outputs of similar age from Trials
#1
of 1 outputs
Altmetric has tracked 21,323,497 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,444 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.9. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 349,618 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them